BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Biphenyl-based small molecule inhibitors: Novel cancer immunotherapeutic agents targeting PD-1/PD-L1 interaction.EBI
Acharya & Bm Reddy College of Pharmacy
Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy.EBI
University of Missouri-Kansas City
Design and Discovery of Natural Cyclopeptide Skeleton Based Programmed Death Ligand 1 Inhibitor as Immune Modulator for Cancer Therapy.EBI
Sun Yat-Sen University
Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway.EBI
China Pharmaceutical University
Grp94 selective inhibitors and uses thereofBDB
University of Kansas
Five-membered heteroaryl ring bridged ring derivative, preparation method therefor and medical use thereofBDB
Jiangsu Hengrui Medicine
Substituted dihydroisoquinolinone compoundsBDB
Pfizer